Spark Investment Management LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 158 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$234,000
-10.7%
6,800
-62.6%
0.32%
+133.8%
Q1 2020$262,000
-57.0%
18,2000.0%0.14%
+95.8%
Q4 2019$609,000
-89.3%
18,200
-91.3%
0.07%
-78.2%
Q3 2018$5,701,000
-8.7%
209,000
-10.0%
0.33%
-10.9%
Q2 2018$6,246,000
+3.7%
232,300
+22.7%
0.37%
-4.9%
Q1 2018$6,025,000189,3000.38%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders